FDA gives TSND-201 breakthrough therapy designation for PTSD
The designation is based on preliminary clinical evidence suggesting substantial improvement over existing therapies, aiming to expedite development and review timelines for promising treatments.
The breakthrough therapy designation is supported by positive results from the IMPACT-I study.
This Phase II trial was a randomised, placebo-controlled study involving 65 patients with severe PTSD.
TSND-201 demonstrated rapid, robust and durable improvements in PTSD symptoms, with statistically significant improvements by day 10 and sustained effects through to day 64.
Transcend Therapeutics co-founder and CEO Blake Mandell stated: "This designation underscores the urgent need for new, more effective treatments for the 13 million Americans living with PTSD.
"Only two FDA-approved medications are available today — and no new PTSD treatments have been approved in over two decades. This breakthrough therapy designation enables us to work more closely with the FDA as we prepare to launch our Phase 3 programme."
University of California San Diego professor of psychiatry and public health and a Transcend consultant Murray B Stein stated: "A rapid-acting, durable treatment for PTSD would be a paradigm shift in psychiatry — and offer a potential lifeline for patients.
"The current treatment standard, SSRIs, can take up to 12 weeks to show maximal effect and often cause side effects during that time. Even then, many patients on SSRIs don't get adequate benefit. This designation offers new hope that faster, more effective treatment may be within reach."
TSND-201 is a proprietary formulation of methylone developed by Transcend Therapeutics. It has well-characterised primary pharmacology, acting primarily at monoamine transporters, with no hallucinogenic activity. Transcend is developing TSND-201 as a rapid-acting and durable treatment for PTSD and other central nervous system indications.
PTSD is a mental health condition that can occur after experiencing or witnessing a life-threatening or traumatic event. Symptoms include flashbacks, nightmares, severe anxiety and uncontrollable thoughts about the event.
PTSD affects 13 million Americans annually, with almost 7% of US adults estimated to be diagnosed during their lifetime.
"FDA gives TSND-201 breakthrough therapy designation for PTSD" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
American Military News
41 minutes ago
- American Military News
Video/Pic: Trump demands drug companies lower prices
President Donald Trump sent 17 pharmaceutical companies letters on Thursday and demanded that the companies lower prices for Americans. The president warned that the 'unacceptable burden' of prescription drug prices will 'end' with his administration. During a press briefing on Thursday, White House Press Secretary Karoline Leavitt said, 'The president signed an executive order earlier this year to solve the problem of exorbitant pharmaceutical pricing.' 'According to recent data, the prices that Americans have been paying for brand-name drugs are more than three times the price other similarly developed nations pay,' Leavitt added. 'The president is determined to solve this problem and took further action today. He has signed 17 letters to pharmaceutical companies' CEOs.' .@PressSec reads one of the letters sent by @POTUS today to the CEOs of pharmaceutical companies: "Moving forward, the only thing I will accept from drug manufacturers is a commitment that provides American families immediate relief from the vastly inflated drug prices…" — Rapid Response 47 (@RapidResponse47) July 31, 2025 Leavitt also shared the letter Trump wrote to the CEO of Eli Lilly and Company. In the letter, Trump warned Eli Lilly and 16 other pharmaceutical companies that the 'unacceptable burden' of brand-name drugs costing 'up to three times higher on average' for Americans than for citizens of other countries 'ends with my administration.' Trump told the pharmaceutical companies, 'Most proposals the Trump administration has received to resolve this critical issue promised more of the same shifting blame and requesting policy changes that would result in billions of dollars in handouts to industry.' The president added, 'Moving forward, the only thing I will accept from drug manufacturers is a commitment that provides American families immediate relief from the vastly inflated drug prices and an end to the free ride of American innovation by European and other developed nations.' READ MORE: Video: Trump order against 'Big Pharma' aims to reduce drug prices While Trump explained that a collaborative effort to reach 'global pricing parity' would be most effective for pharmaceutical companies, the U.S. government, and U.S. patients, he warned that his administration will 'deploy every tool in our arsenal to protect American families' if pharmaceutical companies refuse to take action. In addition to the letter sent to Eli Lilly and Company, Trump sent letters to AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Genentech, Gilead Sciences, GSK, Johnson and Johnson, Merck, Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals, and Sanofi. In the letters, Trump gave the companies 60 days to extend 'Most-Favored-Nation' pricing to Medicaid and provide 'full portfolios' of drugs for Medicaid patients, guarantee Most-Favored-Nation pricing for new drugs, negotiate with 'foreign freeloading nations' and return 'increased revenues abroad' to patients in the United States, and allow Americans to directly purchase drugs at Most-Favored-Nation prices. Today, @POTUS sent letters to 17 drug manufacturers outlining steps they must take to bring down prescription drug prices. If they refuse to step up, the Administration will use every tool to protect Americans from continued abusive drug pricing practices. Letter to Eli Lilly: — Rapid Response 47 (@RapidResponse47) July 31, 2025
USA Today
2 hours ago
- USA Today
The advice you're missing about your pre-workout
Whether you're rolling out of bed at dawn, sacrificing your lunch break for gym time or syncing schedules with a motivated friend to squeeze in an evening workout, the goal is usually about making the most out of every rep, step and minute. While buying better gear, using fitness apps or hiring a personal trainer can all help, a growing number of gym goers are chasing an extra edge through supplementary pills, powders or liquids known as pre-workouts. But do these products really deliver? Here's what they are, which ingredients to watch for and what else you can do beyond supplementation to get the most out of every sweat session. What are pre-workouts? Pre-workouts are dietary supplements designed to reduce muscle fatigue and boost energy, focus, endurance and performance during exercise. Typically taken 20 to 30 minutes before training, they contain a variety of ingredients intended to prime both body and brain for more intense physical effort. Caffeine is the most common and potent ingredient in many of these products because it's a well-established stimulant that enhances alertness and reduces fatigue, at least in the short term. Most pre-workouts contain 150 to 300 milligrams (roughly the amount in 1 to 3 cups of coffee), though some provide even higher (and sometimes unsafe) doses. And while a caffeine boost helps some people, others react poorly. 'Caffeine is not for everyone,' says Bonnie Taub-Dix, a registered dietitian nutritionist and author of "Read It Before You Eat It – Taking You from Label to Table." For some, she says, "caffeine makes them feel jittery or causes an upset stomach." Beyond caffeine, other common ingredients offered in pre-workout supplements include beta-alanine and creatine, plus minerals like zinc and magnesium. Great question: What is magnesium good for? What's the best pre-workout? There's no one-size-fits-all formula since the best pre-workout supplements always depend on one's body, goals and tolerance to certain ingredients. "It's about finding what works for each individual," says Dr. Danielle Ponzio, an orthopedic surgeon who frequently treats athletes at Thomas Jefferson University Hospital in Philadelphia. Ingredients like beta-alanine and creatine are among the most well-researched and effective when properly dosed. No matter which ingredients you're eyeing, label literacy is key. 'Be sure to check labels and look for third-party tested brands to ensure safety and effectiveness,' advises Taub-Dix. That's crucial, since dietary supplements are not regulated by the U.S. Food & Drug Administration (FDA) the way food or medicine are. You'll also want to assess factors like cost, brand reputation, ingredient sourcing and overall quality in any pre-workouts you're considering. And don't overdo it with any ingredient, of course, but be especially cautious when it comes to stimulants. 'Consider how much caffeine you're actually consuming each day across all caffeinated beverages you're drinking and any supplements you're taking,' stresses Taub-Dix. The FDA recommends drinking no more than 400 milligrams daily. It's also wise to steer clear of pre-workout products with "proprietary" blends (which often obscure ingredient amounts), untested stimulants or artificial additives, as they can carry unnecessary risks. Heads up: TikTok Shop is full of supplements for sale. Nutrition experts warn to 'tread carefully.' What's the best way to prepare for a workout? Indeed, nutrition is critical for optimizing performance, regardless of which supplements you add to your diet. 'Your overall nutrition plays the most crucial role in maximizing workout performance and recovery,' says Ponzio. For example, eating a meal or snack high in carbohydrates and moderate in protein one to four hours before exercising can fuel your workout and 'optimize glycogen stores and maintain blood glucose levels,' she explains. Some balanced pre-workout snacks include Greek yogurt with fruit and nuts, oatmeal with almond butter or a smoothie made with yogurt, berries and greens, Taub-Dix says. And she cautions against relying on sugary foods or drinks, which provide only short bursts of energy and may cause digestive discomfort or sugar crashes. Similarly, consuming too much fiber right before exercise "can lead to bloating or sluggishness." Hydration is also key as replacing fluids lost through perspiration helps keep workouts safe and more effective. In the end, the most effective workout prep combines supplements (when needed), nutrition, movement and consistency, habits that pay off both before and after exercise. 'Post-exercise nutrition is also crucial,' says Ponzio. 'It can replenish glycogen stores, repair muscle tissue and rehydrate.'
Newsweek
2 hours ago
- Newsweek
California Removes 900,000 People From Health Care Plan
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hundreds of thousands have been removed from a health care plan in California over the course of two years, according to data from KFF, a nonprofit health policy research and news organization. About 900,000 Americans were disenrolled from Medicaid in the state as part of the unwinding process happening nationwide after Medicaid coverage was expanded following the COVID-19 pandemic. Newsweek has contacted the California Department of Public Health via email for comment. Why It Matters The unwinding process has resulted in significant drops in Medicaid enrollment across the U.S. There is now growing concern about the rising population of those without health insurance and the wider impacts this could have, such as worsening health outcomes, increasing strain on emergency services and rising medical costs. The worry has been amplified by the recent passing of President Donald Trump's One Big Beautiful Bill, in which funding cuts, a focus on "waste, fraud and abuse" and work requirements are in store for Medicaid. Many have voiced concern that the measures will result in millions losing health coverage. File photo: A doctor walks with a young boy through a hospital. File photo: A doctor walks with a young boy through a To Know In California, there were 14,285,643 covered by Medicaid in March 2023, but by March 2025, that number was 13,392,566, KFF data shows. This was because during the pandemic, some states expanded Medicaid coverage under the Affordable Care Act (ACA), causing nationwide enrollment levels to increase. Federal rules forced states to keep most Medicaid enrollees on the program, even if their eligibility status changed, until March 2023, when they were then allowed to start rolling recipients off the program. This marks a change of about 900,000, a decline that was smaller than other highly populated states like Texas, Florida and New York. In March 2025, the number of people with Medicaid coverage in California was still higher than pre-pandemic levels, by 16 percent. The reason why Medicaid coverage is unwinding at different rates in states is because "states approached the process of reviewing the eligibility of their Medicaid beneficiaries with fundamentally different strategies," Michael Sparer, professor and chair of the Department of Health Policy and Management at Columbia University, told Newsweek. He said that Florida and Texas began the review process "as fast as they could and immediately declared ineligible those beneficiaries who did not promptly respond to review notices." "There is clear evidence that many beneficiaries who were still eligible lost coverage simply because they did not timely navigate the administrative hurdles to recertification," he added. Meanwhile, he said that New York and California "were far more deliberate in how they approached the review process, thus the number who've lost their eligibility via this process is far fewer." What People Are Saying Michael Sparer, professor and chair of the Department of Health Policy and Management at Columbia University, told Newsweek: "Medicaid enrollment surged during the pandemic for several reasons, including increased unemployment combined with a requirement that in exchange for additional federal funding, states could not recertify beneficiary eligibility until the "public health emergency" was declared over. Put simply, millions signed up during the pandemic and their eligibility could only be reviewed beginning in the spring 2023. "There is reason to be quite concerned about how this has played out and also what it suggests may happen when Medicaid work requirements, which create their own set of administrative hurdles, are implemented. First, persons who are eligible for coverage should not lose coverage. Bad health outcomes will follow. Second, persons who are no longer Medicaid eligible should be guided to other options, such as subsidized ACA marketplace coverage. Finally, the variation in how states conduct Medicaid eligibility reviews leads to unfortunate inequities." What Happens Next As the unwinding continues, more reductions in enrollment are expected in California and across the country. With millions already having lost health coverage, concerns remain about access to care for low-income individuals and families.
